Evelo Biosciences, Inc. Made Big Gain
Evelo Biosciences, Inc. (EVLO:NASDAQ) jumped higher at $0.2, representing a gain of 101.1%. On Thu, Apr 27, 2023, EVLO:NASDAQ hit a New 2-Week High of $0.2. The stock got featured on our News Catalysts scanner on Wed, Apr 26, 2023 at 08:58 AM in the 'BIOTECH' category. From Thu, Apr 13, 2023, the stock recorded 20.00% Up Days and 18.18% Green Days
The stock spiked on Thu, Apr 27, 2023 at $0.32 with a volume of 182M+.
About Evelo Biosciences, Inc. (EVLO:NASDAQ)
Evelo Biosciences Inc operates as a bio-technology company. The firm develops therapies for the treatment of the gut-body network. Evelo Biosciences also offers treatment for cancer and inflammatory diseases.
Top 10 Gainers:
- Zhong Yang Financial Group Limited (TOP:NASDAQ), 197.62%
- Evelo Biosciences, Inc. (EVLO:NASDAQ), 101.1%
- Hillstream BioPharma Inc. (HILS:NASDAQ), 54.59%
- ContraFect Corporation (CFRX:NASDAQ), 46.97%
- Silence Therapeutics Plc (SLN:NASDAQ), 34.08%
- Atomera Incorporated (ATOM:NASDAQ), 32.76%
- U Power Limited (UCAR:NASDAQ), 32.19%
- Scopus BioPharma Inc. (SCPS:NASDAQ), 24.79%
- SAB Biotherapeutics Inc. (SABS:NASDAQ), 24.74%
- Immix Biopharma Inc. (IMMX:NASDAQ), 24.32%